Cargando…
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease
Parkinson's disease is typically treated with oral dopamine replacement therapies. However, long-term use is complicated by motor fluctuations from intermittent stimulation of dopamine receptors and off-target effects. ProSavin, a lentiviral vector based gene therapy that delivers local and con...
Autores principales: | Palfi, Stéphane, Gurruchaga, Jean Marc, Lepetit, Hélène, Howard, Katy, Ralph, G. Scott, Mason, Sarah, Gouello, Gaëtane, Domenech, Philippe, Buttery, Philip C., Hantraye, Philippe, Tuckwell, Nicola J., Barker, Roger A., Mitrophanous, Kyriacos A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157351/ https://www.ncbi.nlm.nih.gov/pubmed/30156440 http://dx.doi.org/10.1089/humc.2018.081 |
Ejemplares similares
-
A Case of Savin Poisoning
por: Hamilton, John R.
Publicado: (1906) -
G. Vesztergombi and I.A. Savin (Dubna)
por: CERN PhotoLab
Publicado: (1975) -
Notes of a Case of Poisoning with Oil of Savine
por: Sim, J. Brown
Publicado: (1875) -
Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD
por: Iqball, Sharifah, et al.
Publicado: (2023) -
Gene Therapy for Parkinson’s Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis
por: Badin, Romina Aron, et al.
Publicado: (2019)